Skip to main content
ABL Diagnostics logo

ABL Diagnostics — Investor Relations & Filings

Ticker · ABLD ISIN · FR0000063034 LEI · 9695002UO0UHM0VKRH38 PA Manufacturing
Open in API
Filings indexed 126 across all filing types
Latest filing 2026-06-10 M&A Activity
Country FR France
Listing PA ABLD

About ABL Diagnostics

https://www.ablsa.com

ABL Diagnostics is a molecular diagnostics company that develops and commercializes solutions for the diagnosis and management of infectious diseases. The company's offerings include in-vitro diagnostic (IVD) medical devices, PCR-based assays such as the UltraGene product line, and integrated software for data analysis and laboratory automation. ABL Diagnostics also provides the Nadis® electronic medical record (EMR) system for clinical data management. The company specializes in genotyping and sequencing technologies, with a primary focus on monitoring drug resistance in viral infections like HIV and viral hepatitis.

Recent filings

Filing Released Lang Actions
Inside Information / Operations of the issuer (acquisitions, sales...)
M&A Activity Classification · 85% confidence The document is a press release announcing that ABL Diagnostics has submitted a takeover bid to acquire Texcell France, referencing the French Commercial Code and insolvency proceedings. It is an announcement of M&A activity (takeover bid), not a full regulatory filing form or annual/interim report. Therefore it fits the M&A Activity category.
2026-06-10 English
Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
M&A Activity Classification · 91% confidence The document is a regulated press release announcing that ABL Diagnostics has filed a takeover offer (“offre de reprise”) for Texcell France. It contains no financial statements or detailed performance data, but clearly describes an M&A transaction proposal. This matches the “Announcements and documents related to merger proposals or takeover bids” definition for M&A Activity (Code: TAR).
2026-06-10 French
Modalités de mise à disposition des documents préparatoires à l'AG
Declaration of Voting Results & Voting Rights Announcements Classification · 91% confidence The document is a formal announcement under French commerce and AMF regulations providing the total number of shares and voting rights of the company as of a specified date. It specifically relates to the number of voting rights and share capital, which corresponds to Declaration of Voting Results & Voting Rights Announcements (Code DVA). It is not an AGM presentation or a financial report but a statutory voting rights notice.
2026-06-10 French
Terms of availability of the preparatory documents for the GM
Regulatory Filings Classification · 85% confidence The document is a standalone regulatory announcement under French Commercial Code articles L. 233-8 and AMF regulation 223-16, disclosing the total number of shares and voting rights. It does not contain vote results from a shareholder meeting, nor is it presenting a full financial report, management discussion, dividend notice, or capital change. It is a miscellaneous compliance filing that does not fit other specific categories, so it falls under Regulatory Filings (RNS).
2026-06-10 English
Terms of availability of the preparatory documents for the GM
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a formal notice of the Ordinary and Extraordinary General Meeting, providing shareholders with the agenda, text of resolutions, and instructions on where and how to access preparatory materials and participate/vote. This aligns with “Proxy Solicitation & Information Statement” filings, which are distributed to shareholders ahead of meetings to solicit votes and outline resolutions. It is not the actual meeting materials or presentations (AGM-R), nor a post‐meeting voting results announcement (DVA), nor simply a general regulatory announcement (RNS).
2026-06-09 English
Modalités de mise à disposition des documents préparatoires à l'AG
Proxy Solicitation & Information Statement Classification · 65% confidence The document is a convocation notice for the Annual General Meeting (Ordinary and Extraordinary) on June 30, 2026, providing the agenda and instructions for accessing preparatory documents and resolutions. This type of shareholder notification closely aligns with proxy solicitation materials sent to shareholders to inform them of the meeting and request their votes. It is not the AGM presentation itself (AGM-R) nor a simple report publication announcement, so the correct classification is Proxy Solicitation & Information Statement (PSI).
2026-06-09 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.